National Cancer Centre Singapore shared a post on LinkedIn:
“Congratulations to Associate Professor Melvin Chua and his team at the Precision Radiotherapeutics and Oncology Programme at NCCS for their landmark study showing how the tumour microenvironment plays a critical role in the progression of Asian-endemic nasopharyngeal carcinoma, commonly known as nose cancer.
These insights will help clinicians and scientists understand which patients are more likely to respond to immunotherapy and enable more personalised treatment.
To find out more, read our report here.”
More posts featuring National Cancer Centre Singapore.